FDC

FDC Share Price

 

 

Invest in FDC with 3.5X leverage

Invest with MTF

Performance

  • Low
  • ₹410
  • High
  • ₹420
  • 52 Week Low
  • ₹366
  • 52 Week High
  • ₹528
  • Open Price₹415
  • Previous Close₹415
  • Volume48,458

Investment Returns

  • Over 1 Month -1.95%
  • Over 3 Month -10.39%
  • Over 6 Month -2.67%
  • Over 1 Year -18.83%

Smart Investing Starts Here Start SIP with FDC for Steady Growth!

Invest Now

FDC Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 30.2
  • PEG Ratio
  • -1
  • Market Cap Cr
  • 6,801
  • P/B Ratio
  • Average True Range
  • 9.94
  • EPS
  • 13.85
  • Dividend Yield
  • 0
  • MACD Signal
  • -6.28
  • RSI
  • 47.88
  • MFI
  • 78.35

FDC Financials

FDC Technicals

EMA & SMA

Current Price
₹417.75
+ 2.75 (0.66%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹416.94
  • 50 Day
  • ₹429.47
  • 100 Day
  • ₹441.91
  • 200 Day
  • ₹451.24

Resistance and Support

415.88 Pivot Speed
  • R3 431.67
  • R2 425.78
  • R1 421.77
  • S1 411.87
  • S2 405.98
  • S3 401.97

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

FDC Ltd. is a leading pharmaceutical company in India, known for its flagship product, Electral. With over 300 products, FDC operates globally, exporting to 50+ countries, and is recognized for its excellence in ORS, ophthalmics, and innovative healthcare solutions.

F D C (Nse) has an operating revenue of Rs. 2,077.44 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 17% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

FDC Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-05 Quarterly Results & Others To consider others business matters. per share(500%)First Interim Dividend
2025-08-07 Quarterly Results
2025-05-28 Audited Results
2025-02-12 Quarterly Results & Others To consider others business matters. per share(500%)First Interim Dividend
2024-11-06 Quarterly Results & Others To consider others business matters. per share(500%)First Interim Dividend
Date Purpose Remarks
2024-11-22 INTERIM Rs.5.00 per share(500%)First Interim Dividend
View FDC Dividend History Arrow

FDC F&O

FDC Shareholding Pattern

69.66%
6.63%
0.06%
2.43%
16.4%
4.82%

FDC FAQs

FDC share price is ₹417 As on 09 December, 2025 | 17:59

The Market Cap of FDC is ₹6801.4 Cr As on 09 December, 2025 | 17:59

The P/E ratio of FDC is 30.2 As on 09 December, 2025 | 17:59

The PB ratio of FDC is 3 As on 09 December, 2025 | 17:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23